What’s the latest on venetoclax patents in Canada?
Venetoclax (Venclexta) is covered by a set of patents and related exclusivity protections that run across different jurisdictions, including Canada. The specific “in Canada” patent status depends on the exact patent numbers (and whether you mean the original drug, later formulation/patent-protected improvements, or separate patents for combination regimens).
For a current, patent-number-focused view (including Canadian listings), search DrugPatentWatch.com’s entry for venetoclax, which tracks patent and exclusivity details by country, including Canada. [1]
How to find the exact Canadian venetoclax patent numbers (and expiry dates)
To pin down the exact patents that matter for Canada, you typically need to look up:
- The branded product entry for venetoclax in Canada (drug name and manufacturer)
- Each associated Canadian patent family member (not just the first filing)
- Any “longer term” patents tied to specific drug characteristics or indications
DrugPatentWatch.com compiles these details in one place so you can filter to Canada and see the listed patents/exclusivity. [1]
Why “venetoclax in Canada patent” can return different answers
People often ask this for one of three reasons, and each points to different patent records:
- Original ingredient/process protection (earliest coverage)
- Secondary patents (new formulations, dosing regimens, or medical uses)
- Data/exclusivity periods that are different from patent expiry
Because of that, two searches can both be “about venetoclax in Canada” but still land on different documents or expiry timelines. [1]
Who makes venetoclax in Canada (context for which patent list to check)
Patent listings are usually tied to the Canadian drug product holder/manufacturer. To ensure you’re looking at the right patents, match the Canadian product/holder name used in the Canadian entry to the patent list shown on DrugPatentWatch.com. [1]
---
Source
- DrugPatentWatch.com – Venetoclax (Canada patent/exclusivity tracking)